The/DT
effect/NN
of/IN
toremifene/NN
therapy/NN
on/IN
serum/NN
immunoglobulin/NN
levels/NNS
in/IN
breast/NN
cancer/NN
./.

Estrogens/NNS
and/CC
anti-estrogens/NNS
enhance/VBP
the/DT
number/NN
of/IN
immunoglobulin/NN
(/(
Ig/NN
)/)
-secreting/NN
cells/NNS
in/IN
pokeweed/NN
mitogen/NN
(/(
PWM/NN
)/)
-stimulated/JJ
lymphocyte/NN
cultures/NNS
./.
=====
Lymphocytes/NNS
from/IN
patients/NNS
who/WP
have/VBP
received/VBN
anti-estrogen/NN
therapy/NN
show/VBP
similar/JJ
enhancement/NN
of/IN
Ig-secreting/JJ
cells/NNS
after/IN
PWM/NN
stimulation/NN
./.
=====
In/IN
this/DT
study/NN
the/DT
effect/NN
of/IN
anti-estrogen/NN
(/(
toremifene/NN
)/)
therapy/NN
on/IN
serum/NN
immunoglobulin/NN
(/(
IgA/NN
,/,
IgM/NN
,/,
IgG/NN
)/)
levels/NNS
in/IN
breast/NN
cancer/NN
patients/NNS
was/VBD
investigated/VBN
./.
=====
Serum/NN
Ig/NN
levels/NNS
were/VBD
followed/VBN
up/RB
to/TO
two/CD
years/NNS
after/IN
or/CC
during/IN
the/DT
therapy/NN
./.
=====
An/DT
unexpected/JJ
finding/NN
was/VBD
that/IN
the/DT
Ig/NN
levels/NNS
decreased/VBD
during/IN
the/DT
follow-up/JJ
period/NN
./.
=====
This/DT
decrease/NN
was/VBD
seen/VBN
in/IN
patients/NNS
who/WP
responded/VBD
to/TO
the/DT
therapy/NN
as/RB
well/RB
as/IN
in/IN
those/DT
who/WP
did/VBD
not/RB
./.